Structure-based combinatorial library design: Discovery of non-peptidic inhibitors of caspases 3 and 8

被引：1

作者：

Head, MS ^{[1
]}

Ryan, MD

Lee, D

Feng, Y

Janson, CA

Concha, NO

Keller, PM

deWolf, WE

机构：

[1] SmithKline Beecham Pharmaceut, Phys & Struct Chem, King Of Prussia, PA 19406 USA

[2] SmithKline Beecham Pharmaceut, Discovery Chem, King Of Prussia, PA 19406 USA

[3] SmithKline Beecham Pharmaceut, Struct Biol, King Of Prussia, PA 19406 USA

[4] SmithKline Beecham Pharmaceut, Mech Enzymol, King Of Prussia, PA 19406 USA

来源：

JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN | 2001年 / 15卷 / 12期

关键词：

caspase; 3; caspace; 8; inhibitors; structure-based design; combinatorial library;

D O I：

10.1023/A:1015976725743

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Structure-based design of a combinatorial array was carried out in order to identify non-peptidic thiomethylketone inhibitors of caspases 3 and 8. Five compounds from the designed array were active against caspase 3, and two were active against caspase 8. A 2.5-Angstrom resolution co-crystal structure of caspase 3 and a thiomethylketone array member is reported. The structure-based design strategy has proved useful for identifying caspase inhibitors.

引用

页码：1105 / 1117

页数：13

共 50 条

[21] The design of potent, non-peptidic inhibitors of hepatitis C protease
Andrews, DM
Chaignot, HM
Coomber, BA
Dowle, MD
Hind, SL
Johnson, MR
Jones, PS
Mills, G
Patikis, A
Pateman, TJ
Robinson, JE
Slater, MJ
Trivedi, N
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2003, 38 (04) : 339 - 343
[22] Design of peptidic and non-peptidic CD4 inhibitors as novel immunotherapeutic agents
Li, S
Satoh, T
Friedman, TM
Gao, J
Edling, AE
Townsend, R
Koch, U
Choksi, S
Han, X
Shan, S
Aramini, JM
German, MW
Korngold, R
Huang, Z
PEPTIDE SCIENCE - PRESENT AND FUTURE, 1999, : 797 - 800
[23] Structure-based virtual screening against SARS-3CLpro to identify novel non-peptidic hits
Mukherjee, Prasenjit
Desai, Prashant
Ross, Larry
White, E. Lucile
Avery, Mitchell A.
BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (07) : 4138 - 4149
[24] Pyrimidoindolones as potent non-peptidic inhibitors of caspase-3
Havran, LM
Chong, CKD
Aulabaugh, A
Chan, H
Childers, W
Cho, J
Cowling, R
Dollings, PJ
Fennel, M
Harrison, B
Hum, WT
Kapoor, B
Ling, HP
Magolda, RL
Marathias, V
Mosyak, L
Moy, F
Robichaud, AJ
Tawal, GJ
Tsao, D
Wood, A
Xu, WX
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U2657 - U2657
[25] Recent progress in the drug discovery of non-peptidic BACE1 inhibitors
Hamada, Yoshio
Kiso, Yoshiaki
EXPERT OPINION ON DRUG DISCOVERY, 2009, 4 (04) : 391 - 416
[26] Discovery of small non-peptidic CD4 inhibitors as novel immunotherapeutics
Li, S
Gao, JM
Satoh, T
Friedman, TM
Edling, AE
Koch, U
Choksi, S
Han, XB
Korngold, R
Huang, ZW
PEPTIDES: FRONTIERS OF PEPTIDES SCIENCE, 1999, : 517 - 519
[27] Structure-based design of novel HIV protease inhibitors: Sulfonamide-containing 4-hydroxycoumarins and 4-hydroxy-2-pyrones as potent non-peptidic inhibitors
Thaisrivongs, S
Janakiraman, MN
Chong, KT
Tomich, PK
Dolak, LA
Turner, SR
Strohbach, JW
Lynn, JC
Horng, MM
Hinshaw, RR
Watenpaugh, KD
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (12) : 2400 - 2410
[28] Design and bioassay of non-peptidic inhibitors of SARS coronavirus 3C-like proteinase
Liu Ying
Zheng Teng-Fei
Jin Feng
Zhou Lu
Liu Zhen-Ming
Wei Ping
Lai Lu-Hua
ACTA CHIMICA SINICA, 2007, 65 (16) : 1707 - 1712
[29] Structure-directed discovery of potent non-peptidic inhibitors of human urokinase that access a novel binding subsite
Nienaber, VL
Davidson, D
Edalji, R
Giranda, VL
Klinghofer, V
Henkin, J
Magdalinos, P
Mantei, R
Merrick, S
Severin, JM
Smith, RA
Stewart, K
Walter, K
Wang, JY
Wendt, M
Weitzberg, M
Zhao, XM
Rockway, T
STRUCTURE, 2000, 8 (05) : 553 - 563
[30] Recent progress on the discovery of non-peptidic direct renin inhibitors for the clinical management of hypertension
Yokokawa, Fumiaki
EXPERT OPINION ON DRUG DISCOVERY, 2013, 8 (06) : 673 - 690

← 1 2 3 4 5 →